| Method of interfering with cell proliferation |
13297 |
Standard |
29/10/1999 |
Northwestern University |
| System for measuring tissue size and marbling in an animal |
13298 |
Standard |
29/10/1999 |
Pheno Imaging, Inc. |
| Methods using genetic package display for detecting and identifying protein-protein interactions |
13299 |
Standard |
29/10/1999 |
Selective Genetics, Inc. |
| Generalized convolutional interleaver/deinterleaver |
13300 |
Standard |
29/10/1999 |
Broadcom Corporation |
| Fractional-bit transmission using multiplexed constellations |
13301 |
Standard |
29/10/1999 |
Broadcom Corporation |
| Internet gigabit ethernet transmitter architecture |
13302 |
Standard |
29/10/1999 |
Broadcom Corporation |
| Small catalyst particle addition to slurry reactor |
13303 |
Standard |
29/10/1999 |
Exxonmobil Research and Engineering Company |
| Thermal shield |
13304 |
Standard |
29/10/1999 |
Cota, Donald E. |
| Reservoir connector |
13305 |
Standard |
28/10/1999 |
MiniMed, Inc. |
| Providing vcr functionality for data-centered video multicast |
13306 |
Standard |
28/10/1999 |
Matsushita Electric Industrial Co., Ltd. |
| Managing entertainment system data |
13307 |
Standard |
28/10/1999 |
Intel Corporation |
| Use of thiazolidinediones derivatives for preventing uterine contractions in premature labour or lactation |
13308 |
Standard |
29/10/1999 |
Board of Regents of the University of Texas System, The |
| Hyperpolarized helium-3 microbubble gas entrapment methods |
13309 |
Standard |
29/10/1999 |
Medi-Physics, Inc. |
| High fidelity thermostable ligase and uses thereof |
13310 |
Standard |
29/10/1999 |
Cornell Research Foundation Inc. |
| Cancer immunotheraphy and diagnosis using universal tumor associated antigens, including htert |
13311 |
Standard |
29/10/1999 |
Dana-Farber Cancer Institute |
| Controlled release liquid delivery compositions with low initial drug burst |
13312 |
Standard |
28/10/1999 |
Atrix Laboratories, Inc. |
| Determining the location and orientation of an indwelling medical device |
13313 |
Standard |
28/10/1999 |
Lucent Medical Systems, Inc. |
| Heparanase activity neutralizing anti-heparanase monoclonal antibody |
13314 |
Standard |
28/10/1999 |
InSight Biopharmaceuticals Ltd. |
| Maintaining security in a distributed computer network |
13315 |
Standard |
28/10/1999 |
Crosslogix, Inc. |
| Growth factor related molecules |
13316 |
Standard |
28/10/1999 |
Incyte Pharmaceuticals, Inc. |